The DOI matches its Crossref record; 100 of the 100 references it cites were found in a registry or an index.
beta-Lactamases in laboratory and clinical resistance
Open accessAbstract
beta-Lactamases are the commonest single cause of bacterial resistance to beta-lactam antibiotics. Numerous chromosomal and plasmid-mediated types are known and may be classified by their sequences or phenotypic properties. The ability of a beta-lactamase to cause resistance varies with its activity, quantity, and cellular location and, for gram-negative organisms, the permeability of the producer strain. beta-Lactamases sometimes cause obvious resistance to substrate drugs in routine tests; often, however, these enzymes reduce susceptibility without causing resistance at current, pharmacologically chosen breakpoints. This review considers the ability of the prevalent beta-lactamases to cause resistance to widely used beta-lactams, whether resistance is accurately reflected in routine tests, and the extent to which the antibiogram for an organism can be used to predict the type of beta-lactamase that it produces.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Four variants of staphylococcal β-lactamase (A-D) can be distinguished by serotype and currently activity profile [14].”
From Molecular Mechanisms of Drug Resistance in Staphylococcus aureus (2022) · cites this paper as [14]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
National Committee for Clinical Laboratory Standards
Bruck, E. (1980) · Pediatrics · doi:10.1542/peds.65.1.187 · Cited by 14,751
A functional classification scheme for beta-lactamases and its correlation with molecular structure
Bush, K., Jacoby, G. A., & Medeiros, A. A. (1995) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.39.6.1211 · Cited by 2,475
The life and times of the Enterococcus
Murray, B. E. (1990) · Clinical Microbiology Reviews · doi:10.1128/cmr.3.1.46 · Cited by 1,908
Novel Method for Detection of β-Lactamases by Using a Chromogenic Cephalosporin Substrate
O'Callaghan, C. H., Morris, A., Kirby, S. M., & Shingler, A. H. (1972) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.1.4.283 · Cited by 1,837
Ambler, R. P. (1980) · Philosophical Transactions of the Royal Society of London. B, Biological Sciences · doi:10.1098/rstb.1980.0049 · Cited by 1,823
Hartman, B. J., & Tomasz, A. (1984) · Journal of Bacteriology · doi:10.1128/jb.158.2.513-516.1984 · Cited by 890
Enterobacter Bacteremia: Clinical Features and Emergence of Antibiotic Resistance during Therapy
Chow, J. W., Fine, M. J., Shlaes, D. M., Quinn, J. P., Hooper, D. C., Johnson, M. P., Ramphal, R., Wagener, M. M., Miyashiro, D. K., & Yu, V. L. (1991) · Annals of Internal Medicine · doi:10.7326/0003-4819-115-8-585 · Cited by 889
Extended-spectrum beta-lactamases
Philippon, A., Labia, R., & Jacoby, G. (1989) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.33.8.1131 · Cited by 767
More extended-spectrum beta-lactamases
Jacoby, G. A., & Medeiros, A. A. (1991) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.35.9.1697 · Cited by 700
The β-Lactamases of Gram-Negative Bacteria and their Possible Physiological Role
Richmond, M. H., & Sykes, R. B. (1973) · Advances in Microbial Physiology · doi:10.1016/s0065-2911(08)60376-8 · Cited by 690
SERINE β-LACTAMASES AND PENICILLIN-BINDING PROTEINS
Ghuysen, J.-M. (1991) · Annual Review of Microbiology · doi:10.1146/annurev.mi.45.100191.000345 · Cited by 628
Transferable imipenem resistance in Pseudomonas aeruginosa
Watanabe, M., Iyobe, S., Inoue, M., & Mitsuhashi, S. (1991) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.35.1.147 · Cited by 619
Nosocomial Outbreak of Klebsiella Infection Resistant to Late-Generation Cephalosporins
Meyer, K. S., Urban, C., Eagan, J. A., Berger, B. J., & Rahal, J. J. (1993) · Annals of Internal Medicine · doi:10.7326/0003-4819-119-5-199309010-00001 · Cited by 580
The β-lactamases of Gram-negative bacteria and their rôle in resistance to β-lactam antibiotics
Sykes, R. B., & Matthew, M. (1976) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/2.2.115 · Cited by 536
Osano, E., Arakawa, Y., Wacharotayankun, R., Ohta, M., Horii, T., Ito, H., Yoshimura, F., & Kato, N. (1994) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.38.1.71 · Cited by 440
Evolution of plasmid-coded resistance to broad-spectrum cephalosporins
Kliebe, C., Nies, B. A., Meyer, J. F., Tolxdorff-Neutzling, R. M., & Wiedemann, B. (1985) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.28.2.302 · Cited by 415
Rice, L. B., Willey, S. H., Papanicolaou, G. A., Medeiros, A. A., Eliopoulos, G. M., Moellering, R. C., & Jacoby, G. A. (1990) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.34.11.2193 · Cited by 376
Sirot, D., Sirot, J., Labia, R., Morand, A., Courvalin, P., Darfeuille-Michaud, A., Perroux, R., & Cluzel, R. (1987) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/20.3.323 · Cited by 358
-Lactam Resistance in Gram-Negative Bacteria: Global Trends and Clinical Impact
Sanders, C. C., & Sanders, W. E. (1992) · Clinical Infectious Diseases · doi:10.1093/clind/15.5.824 · Cited by 334
Sykes, R. B., Bonner, D. P., Bush, K., & Georgopapadakou, N. H. (1982) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.21.1.85 · Cited by 314
Papanicolaou, G. A., Medeiros, A. A., & Jacoby, G. A. (1990) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.34.11.2200 · Cited by 313
Jorgensen, J. H., Doern, G. V., Maher, L. A., Howell, A. W., & Redding, J. S. (1990) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.34.11.2075 · Cited by 310
Characterization of beta-lactamases
Bush, K. (1989) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.33.3.259 · Cited by 305
Livermore, D. M. (1992) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.36.9.2046 · Cited by 288
Self-citationLi, X. Z., Ma, D., Livermore, D. M., & Nikaido, H. (1994) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.38.8.1742 · Cited by 278
Self-citationMurray, B. E., & Mederski-Samaroj, B. (1983) · Journal of Clinical Investigation · doi:10.1172/jci111042 · Cited by 253
ARI 1: β-lactamase-mediated imipenem resistance in Acinetobacter baumannii
Paton, R., Miles, R. S., Hood, J., Amyes, S. G. B., Miles, R. S., & Amyes, S. G. B. (1993) · International Journal of Antimicrobial Agents · doi:10.1016/0924-8579(93)90045-7 · Cited by 245
Jacoby, G. A., & Carreras, I. (1990) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.34.5.858 · Cited by 227
Plasmid-mediated β-lactamases of Gram-negative bacteria: properties and distribution
Matthew, M. (1979) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/5.4.349 · Cited by 221
Ceftazidime Resistance Among Selected Nosocomial Gram-Negative Bacilli In The United States
Burwen, D. R., Banerjee, S. N., Gaynes, R. P., & System, T. N. N. I. S. (1994) · Journal of Infectious Diseases · doi:10.1093/infdis/170.6.1622 · Cited by 214
Clinical significance of beta-lactamase induction and stable derepression in gram-negative rods
Livermore, D. M. (1987) · European Journal of Clinical Microbiology · doi:10.1007/bf02013107 · Cited by 210
Self-citationCharacterization of a novel extended-spectrum beta-lactamase from Pseudomonas aeruginosa
Nordmann, P., Ronco, E., Naas, T., Duport, C., Michel-Briand, Y., & Labia, R. (1993) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.37.5.962 · Cited by 201
An overview of the kinetic parameters of class B β -lactamases
Felici, A., Amicosante, G., Oratore, A., Ström, R., Ledent, P., Joris, B., Fanuel, L., & Frère, J. (1993) · Biochemical Journal · doi:10.1042/bj2910151 · Cited by 198
Naumovski, L., Quinn, J. P., Miyashiro, D., Patel, M., Bush, K., Singer, S. B., Graves, D., Palzkill, T., & Arvin, A. M. (1992) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.36.9.1991 · Cited by 189
Quinn, J. P., Miyashiro, D., Sahm, D., Flamm, R., & Bush, K. (1989) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.33.9.1451 · Cited by 187
Naas, T., Vandel, L., Sougakoff, W., Livermore, D. M., & Nordmann, P. (1994) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.38.6.1262 · Cited by 184
Self-citationExtended broad spectrum β-lactamase in Klebsiella pneumoniae including resistance to cephamycins
Bauernfeind, A., Schweighart, S., & Chong, Y. (1989) · Infection · doi:10.1007/bf01650718 · Cited by 182
Nikaido, H., & Normark, S. (1987) · Molecular Microbiology · doi:10.1111/j.1365-2958.1987.tb00523.x · Cited by 180
Emergence of Resistance to Cefamandole: Possible Role of Cefoxitin-Inducible Beta-Lactamases
Sanders, C. C., & Sanders, W. E. (1979) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.15.6.792 · Cited by 179
Vu, H., & Nikaido, H. (1985) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.27.3.393 · Cited by 178
Sabath, L. D., Garner, C., Wilcox, C., & Finland, M. (1975) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.8.3.344 · Cited by 177
Doern, G. V., Jorgensen, J. H., Thornsberry, C., et al. (1988) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.32.2.180 · Cited by 173
Piperacillin, a new penicillin active against many bacteria resistant to other penicillins
Fu, K. P., & Neu, H. C. (1978) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.13.3.358 · Cited by 169
The diversity of the catalytic properties of class A β-lactamases
Matagne, A., Misselyn-Bauduin, A. M., Joris, B., Erpicum, T., Granier, B., & Frère, J. M. (1990) · Biochemical Journal · doi:10.1042/bj2650131 · Cited by 167
Urban, C., Go, E., Mariano, N., Berger, B. J., Avraham, I., Rubin, D., & Rahal, J. J. (1993) · Journal of Infectious Diseases · doi:10.1093/infdis/167.2.448 · Cited by 164
Yang, Y. J., Wu, P. J., & Livermore, D. M. (1990) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.34.5.755 · Cited by 163
Self-citationNordmann, P., Mariotte, S., Naas, T., Labia, R., & Nicolas, M. H. (1993) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.37.5.939 · Cited by 161
Blázquez, J., Baquero, M.-R., Cantón, R., Alós, J.-I., & Baquero, F. (1993) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.37.10.2059 · Cited by 152
Novel plasmid-mediated beta-lactamase from Escherichia coli that inactivates oxyimino-cephalosporins
Matsumoto, Y., Ikeda, F., Kamimura, T., Yokota, Y., & Mine, Y. (1988) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.32.8.1243 · Cited by 145
Parker, A. C., & Smith, C. J. (1993) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.37.5.1028 · Cited by 144
Susceptibility of the Bacteroides fragilis group in the United States: analysis by site of isolation
Cuchural, G. J., Tally, F. P., Jacobus, N. V., Aldridge, K. E., Cleary, T., Finegold, S. M., Hill, G. B., Iannini, P. B., O'Keefe, J. P., & Pierson, C. L. (1988) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.32.5.717 · Cited by 143
Pangon, B., Bizet, C., Buré, A., Pichon, F., Philippon, A., Regnier, B., & Gutmann, L. (1989) · The Journal of Infectious Diseases · doi:10.1093/infdis/159.5.1005 · Cited by 142
Bradford, P. A., Cherubin, C. E., Idemyor, V., Rasmussen, B. A., & Bush, K. (1994) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.38.4.761 · Cited by 133
Lee, E. H., Nicolas-Chanoine, M.-H., Kitzis, M.-D., Pialoux, G., Collatz, E., & Gutmann, L. (1991) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.35.6.1093 · Cited by 131
Arakawa, Y., Ohta, M., Kido, N., Mori, M., Ito, H., Komatsu, T., Fujii, Y., & Kato, N. (1989) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.33.1.63 · Cited by 123
Chen, H. Y., Yuan, M., & Livermore, D. M. (1995) · Journal of Medical Microbiology · doi:10.1099/00222615-43-4-300 · Cited by 122
Self-citationZhou, X. Y., Bordon, F., Sirot, D., Kitzis, M.-D., & Gutmann, L. (1994) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.38.5.1085 · Cited by 121
Kayser, F. H., Morenzoni, G., & Santanam, P. (1990) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/bf01967379 · Cited by 118
PENICILLIN-RESISTANT NEISSERIA MENINGITIDIS IN SOUTHERN AFRICA
Botha, P. (1988) · The Lancet · doi:10.1016/s0140-6736(88)91029-x · Cited by 116
Videl, G., Belaaouaj, A., Gilly, L., Labia, R., Philippon, A., Névot, P., & Paul, G. (1992) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/30.4.449 · Cited by 115
Resistance of Bacteria to Antibacterial Agents: Report of Task Force 2
O’Brien, T. (1987) · Clinical Infectious Diseases · doi:10.1093/clinids/9.supplement_3.s244 · Cited by 112
Properties of novel beta-lactamase produced by Bacteroides fragilis
Yotsuji, A., Minami, S., Inoue, M., & Mitsuhashi, S. (1983) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.24.6.925 · Cited by 112
Leiza, M. G., Pérez-Díaz, J. C., Ayala, J. A., Casellas, J. M., Martínez-Beltrán, J., Bush, K., & Baquero, F. (1994) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.38.9.2150 · Cited by 111
Molecular basis of beta-lactamase induction in bacteria
Bennett, P. M., & Chopra, I. (1993) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.37.2.153 · Cited by 109
de Champs, C., Sirot, D., Chanal, C., Poupart, M. C., Dumas, M.-P., & Sirot, J. (1991) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/27.4.441 · Cited by 108
Hancock, R. E. W., & Bellido, F. (1992) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/29.suppl_a.1 · Cited by 105
Characterization of four beta-lactamases produced by Staphylococcus aureus
Zygmunt, D. J., Stratton, C. W., & Kernodle, D. S. (1992) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.36.2.440 · Cited by 102
Livermore, D. M., & Yang, Y.-J. (1987) · The Journal of Infectious Diseases · doi:10.1093/infdis/155.4.775 · Cited by 101
Self-citationDeterminants of the activity of -lactamase inhibitor combinations
Livermore, D. M. (1993) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/31.suppl_a.9 · Cited by 98
Self-citationFailure of Cephalosporins to Prevent Staphylococcus aureus Surgical Wound Infections
Kernodle, D. S., Classen, D. C., Burke, J. F., & Kaiser, A. B. (1990) · JAMA · doi:10.1001/jama.1990.03440070049031 · Cited by 97
KUCK, N. A., Jacobus, N. V., Petersen, P. J., Weiss, J., & TESTA, R. T. (1989) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.33.11.1964 · Cited by 95
A comparative study of class-D β-lactamases
Ledent, P., Raquet, X., Joris, B., BEEUMEN, J. V., & Frère, J. (1993) · Biochemical Journal · doi:10.1042/bj2920555 · Cited by 94
Transferable production of PER-1 β-lactamase in Pseudomonas aeruginosa
Danel, F., Hall, L. M. C., Gür, D., Akalın, H., & Livermore, D. M. (1995) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/35.2.281 · Cited by 91
Self-citationAkova, M., Yang, Y., & Livermore, D. M. (1990) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/25.2.199 · Cited by 90
Self-citationImipenem- and meropenem-resistant mutants of Enterobacter cloacae and Proteus rettgeri lack porins
Raimondi, A., Traverso, A., & Nikaido, H. (1991) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.35.6.1174 · Cited by 89
Sanders, C. C., Iaconis, J. P., Bodey, G. P., & Samonis, G. (1988) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.32.9.1365 · Cited by 87
Rice, L. B., Yao, J. D. C., Klimm, K., Eliopoulos, G. M., & Moellering, R. C. (1991) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.35.6.1243 · Cited by 86
Distribution and resistance patterns ofHaemophilus influenzae: A European cooperative study
Machka, K., Braveny, I., Dabernat, H., Dornbusch, K., Dyck, E. V., Kayser, F. H., Klingeren, B. V., Mittermayer, H., Perea, E., & Powell, M. (1988) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/bf01962165 · Cited by 82
A novel plasmid-medlated extended-spectrum β-lactamase not derived from TEM- or SHV-type enzymes
BERNARD, H., Tancrède, C., Livrelli, V., Morand, A., Barthélémy, M., & Labia, R. (1992) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/29.5.590 · Cited by 80
Mett, H., Rosta, S., Engstler, B. S., & Frei, R. (1988) · Clinical Infectious Diseases · doi:10.1093/clinids/10.4.765 · Cited by 75
Wu, P. J., Shannon, K. P., & Phillips, I. R. (1994) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.38.3.494 · Cited by 71
Urban, C. M., Go, E., Mariano, N., & Rahal, J. J. (1995) · FEMS Microbiology Letters · doi:10.1111/j.1574-6968.1995.tb07357.x · Cited by 71
Survival of multiply-resistant Klebsiella aerogenes and other Gram-negative bacilli on finger-tips
Casewell, M. W., & Desai, N. (1983) · Journal of Hospital Infection · doi:10.1016/0195-6701(83)90005-1 · Cited by 68
Mechanisms of beta-lactam resistance in british isolates of Pseudomonas aeruginosa
WILLIAMS, R. J., Livermore, D. M., Lindridge, M., Said, A. A., & Williams, J. D. (1984) · Journal of Medical Microbiology · doi:10.1099/00222615-17-3-283 · Cited by 68
Self-citationClinical importance of inducible beta-lactamases in gram-negative bacteria
Sanders, C. C., & Sanders, W. E. (1987) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/bf02013106 · Cited by 64
ß-Lactamase: mechanism of action
Waley, S. G. (1992) · Springer eBooks · doi:10.1007/978-94-011-2928-2_6 · Cited by 64
TRC-1: Emergence of a clavulanic acid-resistant TEM β-lactamase in a clinical strain
Thomson, C. J. (1992) · FEMS Microbiology Letters · doi:10.1016/0378-1097(92)90669-f · Cited by 57
Molecular epidemiology of TEM-3 (CTX-1) beta-lactamase
Petit, A., Gerbaud, G., Sirot, D., et al. (1990) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.34.2.219 · Cited by 57
Kernodle, D. S., McGraw, P. A., Stratton, C. W., & Kaiser, A. B. (1990) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.34.3.420 · Cited by 53
Olsson, O., Bergström, S., Lindberg, F. P., et al. (1983) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.80.24.7556 · Cited by 52
Antimicrobial resistance in Haemophilus influenzae from England and Scotland in 1991
Powell, M., Fah, Y. S., Seymour, A., Yuan, M., & Williams, J. D. (1992) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/29.5.547 · Cited by 52
Detection of .BETA.-lactamase production by gram-negative bacteria.
MASUDA, G., Tomioka, S., & Hasegawa, M. (1976) · The Journal of Antibiotics · doi:10.7164/antibiotics.29.662 · Cited by 49
Mendelman, P. M., Chaffin, D. O., Clausen, C. R., Stull, T. L., Needham, C. A., Williams, J. D., & Smith, A. L. (1986) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.30.2.274 · Cited by 45
Daum, R. S., Murphey‐Corb, M., Shapira, E., & Dipp, S. (1988) · The Journal of Infectious Diseases · doi:10.1093/infdis/157.3.450 · Cited by 44
Beta-Lactamase Inhibitors and the Inducibility of the Beta-Lactamase of Mycobacterium tuberculosis
Zhang, Y., STEINGRUBE, V. A., & Wallace, R. J. (1992) · American Review of Respiratory Disease · doi:10.1164/ajrccm/145.3.657 · Cited by 37
Barnes, J. M. (1947) · The Journal of Pathology and Bacteriology · doi:10.1002/path.1700590113 · Cited by 29
Effect of media composition on the susceptibility of Xanthomonas mahophilia to β -lactam antibiotics
Bonfiglio, G., & Livermore, D. M. (1991) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/28.6.837 · Cited by 27
Self-citationLivermore, D. M., & Davy, K. W. M. (1991) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.35.5.916 · Cited by 24
Self-citationBauernfeind, A. (1990) · Infection · doi:10.1007/bf01644185 · Cited by 23
Yeo, S.-F., & Livermore, D. M. (1994) · Journal of Medical Microbiology · doi:10.1099/00222615-40-4-252 · Cited by 12
Self-citation
Cited by
Extended-Spectrum β-Lactamases: a Clinical Update
Paterson, D. L., & Bonomo, R. A. (2005) · Clinical Microbiology Reviews · doi:10.1128/cmr.18.4.657-686.2005 · Cited by 3,491
Bradford, P. A. (2001) · Clinical Microbiology Reviews · doi:10.1128/cmr.14.4.933-951.2001 · Cited by 2,618
Multiple Mechanisms of Antimicrobial Resistance in Pseudomonas aeruginosa: Our Worst Nightmare?
Livermore, D. M. (2002) · Clinical Infectious Diseases · doi:10.1086/338782 · Cited by 1,453
Self-citationGold, H. S., & Moellering, R. C. (1996) · New England Journal of Medicine · doi:10.1056/nejm199611073351907 · Cited by 1,070
CTX-M Enzymes: Origin and Diffusion
Cantón, R., González-Alba, J. M., & Galán, J. C. (2012) · Frontiers in Microbiology · doi:10.3389/fmicb.2012.00110 · Cited by 974
Metadata
- Authors
- Livermore, D. M.
- Venue
- Clinical Microbiology Reviews
- Publisher
- American Society for Microbiology
- Published
- 1995-10
- Volume
- 8
- Issue
- 4
- Pages
- 557-584
- ISSN
- 0893-8512 (ISSN-L)
- 1098-6618
- OpenAlex
- W2121867408
- Cited by
- 1,779
- References
- 100
- FWCI
- 16.99
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.